We found that breast cancer cells with RON and DEK loss of function harbor independent dysregulation of defined lipid metabolites, including cholesterol, unsaturated fatty acids, glycerol, sphingomyelin, and glycerophospholipids. Here, DEK is linked to breast carcinoma.